BRIEF-AstraZeneca, Ironwood agree U.S. licensing agreement By: Reuters: Company News April 26, 2016 at 04:37 AM EDT * Agreement includes U.S. rights to zurampic and lesinurad/allopurinol fixed-dose combination in gout Read More >> Related Stocks: Astrazeneca Plc ADR Ironwood Pharmaceuti